Related Research Articles
Rheumatism or rheumatic disorders are conditions causing chronic, often intermittent pain affecting the joints or connective tissue. Rheumatism does not designate any specific disorder, but covers at least 200 different conditions, including arthritis and "non-articular rheumatism", also known as "regional pain syndrome" or "soft tissue rheumatism". There is a close overlap between the term soft tissue disorder and rheumatism. Sometimes the term "soft tissue rheumatic disorders" is used to describe these conditions.
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan Biovitrum. Anakinra is administered by subcutaneous injection.
Nature Reviews Rheumatology is a monthly peer-reviewed medical journal published by the Nature Portfolio. It was established in 2005 as Nature Clinical Practice Rheumatology and obtained its current title in 2009. The journal covers all aspects of rheumatology. The editor-in-chief is Sarah Onuora.
Synovitis is the medical term for inflammation of the synovial membrane. This membrane lines joints that possess cavities, known as synovial joints. The condition is usually painful, particularly when the joint is moved. The joint usually swells due to synovial fluid collection.
PLOS One is a peer-reviewed open access mega journal published by the Public Library of Science (PLOS) since 2006. The journal covers primary research from any discipline within science and medicine. The Public Library of Science began in 2000 with an online petition initiative by Nobel Prize winner Harold Varmus, formerly director of the National Institutes of Health and at that time director of Memorial Sloan–Kettering Cancer Center; Patrick O. Brown, a biochemist at Stanford University; and Michael Eisen, a computational biologist at the University of California, Berkeley, and the Lawrence Berkeley National Laboratory.
Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of fevers, joint pain, and a distinctive salmon-colored bumpy rash. The disease is considered a diagnosis of exclusion. Levels of the iron-binding protein ferritin may be extremely elevated with this disorder. AOSD may present in a similar manner to other inflammatory diseases and to autoimmune diseases, which must be ruled out before making the diagnosis.
James T. Rosenbaum is an American physician-scientist who is Senior Vice President for Research at Corvus Pharmaceuticals and Chief of Ophthalmology emeritus at the Legacy Devers Eye Institute, Portland, Oregon, where he held the Richard Chenoweth Chair. Previously, he was Chief of Arthritis and Rheumatic Diseases at the Oregon Health & Science University where he held the Edward E Rosenbaum Professorship in Inflammation Research. Rosenbaum was the only practicing rheumatologist/non-ophthalmologist in the world to serve as a chief of ophthalmology. He is recognized for his description of an animal model of uveitis resulting from injection of bacterial endotoxin and for more than 600 scholarly publications, mostly related to the intersection between rheumatology and ophthalmology. He is a co-author of the book, "The Clinical Neurology of Rheumatic Diseases".
Gabrielle T. Belz is an Australian molecular immunologist and viral immunologist. She is a faculty member of the Walter and Eliza Hall Institute of Medical Research, within the Molecular Immunology division. Belz has made important contributions to the understanding of immune system function, especially in relation to the molecular and cellular signalling pathways of immune response to viruses. Her research has focused on understanding the signals that drive the initial development of protective immunity against pathogen infections, such as influenza and herpes viruses. This includes research into how cytotoxic T cells recognise and remove virally-infected cells from the body following infection. Research into the description of the specific factors and response during infection will contribute towards the long-term development of vaccines for infectious disease, and the development of better treatments for autoimmune diseases.
Sarah M. Assmann is an American biologist known for her research on plants and signal transduction. She is an elected fellow of the American Association for the Advancement of Science.
Relapsing–remitting is a medical term referring to a presentation of disease symptoms that become worse over time (relapsing), followed by periods of less severe symptoms that do not completely cease. The term is used to describe a type of multiple sclerosis called relapsing–remitting multiple sclerosis, where unpredictable relapses are followed by remission for months to years.
Gary S. Firestein is an American rheumatologist, professor, and founding director of the Altman Clinical and Translational Research Institute (ACTRI) at the University of California San Diego and Senior Associate Vice Chancellor for Health Sciences at University of California, San Diego.
Paul-Peter Tak M.D. PhD FMedSci is an immunologist and academic specialising in the fields of internal medicine, rheumatology and immunology. Tak has been the President & CEO of Candel Therapeutics since September 2020.
This is a list of several significant scientific events that occurred or were scheduled to occur in 2021.
Prime editing is a 'search-and-replace' genome editing technology in molecular biology by which the genome of living organisms may be modified. The technology directly writes new genetic information into a targeted DNA site. It uses a fusion protein, consisting of a catalytically impaired Cas9 endonuclease fused to an engineered reverse transcriptase enzyme, and a prime editing guide RNA (pegRNA), capable of identifying the target site and providing the new genetic information to replace the target DNA nucleotides. It mediates targeted insertions, deletions, and base-to-base conversions without the need for double strand breaks (DSBs) or donor DNA templates.
Dame Sarah Catherine Gilbert FRS is an English vaccinologist who is a Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. She specialises in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011.
VEXAS syndrome is an adult-onset autoinflammatory disease primarily affecting males, caused by a somatic mutation of the UBA1 gene in hematopoietic progenitor cells. The name VEXAS is an acronym deriving from the core features of disease:
Nerve growth factor (NGF) inhibitors are a class of compounds that inhibit the action of the neurotrophin nerve growth factor by targeting NGF molecules or NGF receptors. NGF inhibitors have demonstrated therapeutic potential in treatment of certain chronic pain disorders, including osteoarthritis, and chronic lower back pain. Two NGF inhibitors are undergoing clinical trials as potential treatments for pain disorders.
Katrina Ray is a biologist and the chief editor of Nature Reviews Gastroenterology & Hepatology.
MEDI7352 is an experimental non-opioid analgesic drug that works as a bispecific monoclonal antibody against tumour necrosis factor (TNF) and nerve growth factor (NGF); it is developed by AstraZeneca for chronic pain.
Rebecca Grainger is a New Zealand academic rheumatologist, and is a full professor at the University of Otago, specialising in rheumatoid arthritis and osteoarthritis, and gout. She is also interested in the use of technology for medical education and digital health.
References
- 1 2 3 "About the Editors | Nature Reviews Rheumatology". www.nature.com. Retrieved 2022-04-03.
- ↑ Onuora, Sarah (Sep 2021). "Antibodies induce fibromyalgia symptoms". Nature Reviews. Rheumatology. 17 (9): 507. doi:10.1038/s41584-021-00679-y. ISSN 1759-4804. PMID 34354268. S2CID 236921180.
- ↑ Taylor, Peter C. "Aetiopathology of rheumatoid arthritis." Medicine 42.5 (2014): 227-230.
